Ocular Therapeutix™ adopts BSI’s CTMS software for its Ophthalmology clinical trials
BSI Life Sciences today announced biopharma Ocular Therapeutix (NASDAQ: OCUL) as its latest client to go live with its c…
BSI Life Sciences today announced biopharma Ocular Therapeutix (NASDAQ: OCUL) as its latest client to go live with its c…
With DropControl, Gerresheimer has developed a new dropper insert for modern drugs with low viscosity for ophthalmology,…
Evolva (SIX: EVE) announces that it is expanding its current work with the US Centers for Disease Control (CDC) to resea…
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoim…
bitop AG, a biotech company specializing in the development of Ectoin®-containing medical devices, announced the inclusi…
bitop AG, a biotech company specializing in the development of Ectoincontaining medical devices, reports that Ectoin all…